(Total Views: 567)
Posted On: 08/29/2025 7:03:56 PM
Post# of 156758
Google Ai
Swayampakula "RK" Ramakanth, Ph.D., is still a Managing Director of Equity Research at H.C. Wainwright & Co. Despite his profile being absent from a general list on the firm's website, he is consistently mentioned as an analyst there on investor relations pages for companies he covers and in recent press releases.
Ramakanth's continued role at H.C. Wainwright
Multiple sources confirm Dr. Ramakanth remains with the firm and actively covers stocks in the biotechnology sector.
Active analyst coverage: As recently as August 2025, Dr. Ramakanth participated in a virtual fireside chat hosted by H.C. Wainwright for the biopharmaceutical company Precigen, Inc.
Professional profiles: His LinkedIn profile states he has been a Managing Director/Senior Equity Analyst at H.C. Wainwright since June 2014.
Updated company websites: His profile appears on the investor relations pages of companies he covers, such as Delcath Systems, listing his affiliation with H.C. Wainwright.
Reason for omission from general list
The absence of his name from a general firm list on the H.C. Wainwright website could be due to an administrative oversight, a website update, or the firm's specific internal organization. However, the continued mention of his name in recent external sources makes it clear he remains an active and current analyst at the firm.
Swayampakula "RK" Ramakanth, Ph.D., is still a Managing Director of Equity Research at H.C. Wainwright & Co. Despite his profile being absent from a general list on the firm's website, he is consistently mentioned as an analyst there on investor relations pages for companies he covers and in recent press releases.
Ramakanth's continued role at H.C. Wainwright
Multiple sources confirm Dr. Ramakanth remains with the firm and actively covers stocks in the biotechnology sector.
Active analyst coverage: As recently as August 2025, Dr. Ramakanth participated in a virtual fireside chat hosted by H.C. Wainwright for the biopharmaceutical company Precigen, Inc.
Professional profiles: His LinkedIn profile states he has been a Managing Director/Senior Equity Analyst at H.C. Wainwright since June 2014.
Updated company websites: His profile appears on the investor relations pages of companies he covers, such as Delcath Systems, listing his affiliation with H.C. Wainwright.
Reason for omission from general list
The absence of his name from a general firm list on the H.C. Wainwright website could be due to an administrative oversight, a website update, or the firm's specific internal organization. However, the continued mention of his name in recent external sources makes it clear he remains an active and current analyst at the firm.
(7)
(0)
